Per Svenningsen Selected Research

Per Svenningsen Research Topics

Disease

14	Hypertension (High Blood Pressure) 01/2024 - 11/2012
13	Proteinuria 01/2022 - 09/2011
13	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 02/2009
7	Albuminuria 03/2024 - 03/2015
5	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 01/2012
5	Pre-Eclampsia (Preeclampsia) 01/2024 - 01/2012
3	Type 2 Diabetes Mellitus (MODY) 03/2024 - 08/2014
3	Inflammation (Inflammations) 01/2022 - 11/2017
3	Fibrosis (Cirrhosis) 01/2021 - 11/2017
3	Nephrosis 12/2019 - 03/2015
2	Hypoxia (Hypoxemia) 09/2023 - 01/2021
2	Hypercalcemia (Milk Alkali Syndrome) 01/2021 - 01/2021
2	Edema (Dropsy) 03/2020 - 08/2015
1	Alkalosis 01/2024
1	Liddle Syndrome 01/2024
1	Hypokalemia 01/2024
1	Ischemia 10/2023
1	Nephrogenic Diabetes Insipidus 10/2022
1	Insulin Resistance 01/2021
1	Kidney Calculi (Kidney Stone) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Obesity 01/2021
1	Hypercalciuria 01/2021
1	Diabetes Mellitus 12/2020
1	Diabetes Complications 12/2020
1	Weight Gain 02/2020
1	Ascites 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Glioma (Gliomas) 10/2018
1	Seizures (Absence Seizure) 10/2018
1	Hydronephrosis 01/2018
1	Kidney Diseases (Kidney Disease) 11/2017
1	Disease Progression 11/2017
1	Chronic Disease (Chronic Diseases) 03/2015

Drug/Important Bio-Agent (IBA)

15	Fibrinolysin FDA Link 12/2020 - 02/2009
9	SodiumIBA 01/2022 - 01/2012
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
8	PlasminogenIBA 12/2020 - 02/2009
7	AldosteroneIBA 01/2024 - 03/2015
6	ReninIBA 01/2024 - 03/2015
6	prostasinIBA 01/2022 - 01/2015
6	Amiloride (Midamor)FDA LinkGeneric 12/2020 - 03/2015
6	Epithelial Sodium ChannelsIBA 12/2020 - 02/2009
6	Peptide Hydrolases (Proteases)FDA Link 12/2019 - 09/2011
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2019 - 02/2009
4	SaltsIBA 01/2024 - 03/2015
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 03/2015
3	Puromycin AminonucleosideIBA 12/2019 - 01/2012
3	FurinIBA 12/2019 - 01/2015
3	Serine Proteases (Serine Protease)IBA 01/2018 - 01/2012
3	estropipate (Ogen)FDA LinkGeneric 01/2017 - 11/2012
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 03/2024 - 01/2022
2	Complement System Proteins (Complement)IBA 03/2024 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2022
2	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2022
2	CytokinesIBA 01/2024 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 09/2023
2	AngiotensinsIBA 01/2022 - 01/2017
2	claudin 14IBA 01/2021 - 01/2021
2	Angiotensin IIIBA 12/2020 - 03/2015
2	Kallikreins (Kallikrein)IBA 03/2015 - 01/2015
2	DiureticsIBA 03/2015 - 08/2014
1	LectinsIBA 03/2024
1	Collectins (Collectin)IBA 03/2024
1	dapagliflozinIBA 03/2024
1	InterleukinsIBA 01/2024
1	Aquaporin 2IBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	complement C3d,gIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	InterferonsIBA 01/2022
1	AdiponectinIBA 01/2021
1	Calcium-Sensing ReceptorsIBA 01/2021
1	H-cadherin (T-cadherin)IBA 01/2021
1	AdipokinesIBA 01/2021
1	Prorenin ReceptorIBA 12/2020
1	Calcium Channels (Calcium Channel)IBA 02/2020
1	CholesterolIBA 02/2020
1	Adenosine Triphosphatases (ATPase)IBA 12/2019
1	NPHS2 proteinIBA 12/2019
1	Member 3 Solute Carrier Family 12IBA 12/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2018
1	SynaptophysinIBA 10/2018
1	CreatinineIBA 01/2018
1	CalciumIBA 11/2017
1	PAR-1 ReceptorIBA 11/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2017
1	Transient Receptor Potential ChannelsIBA 11/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 03/2015
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2014
1	AlbuminsIBA 08/2014

Therapy/Procedure

1	Catheters 01/2017
1	Nephrotomy 01/2017
1	Nephrectomy 01/2017